Benznidazole - 97%, high purity , CAS No.22994-85-0

  • ≥97%
Item Number
B133189
Grouped product items
SKUSizeAvailabilityPrice Qty
B133189-5mg
5mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$19.90
B133189-25mg
25mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$80.90
B133189-100mg
100mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$178.90

Basic Description

SynonymsAS-68694 | benznidazole (TN) | Benznidazole [INN] | Radanil (TN) | Z2044771577 | Acetamide, N-benzyl-2-(nitroimidazol-1-yl)- | Benznidazole (USAN/INN) | DB11989 | FT-0662547 | Ro 07-1051;Ro 71051 | BENZNIDAZOLE [MART.] | Benznidazolum | N-benzyl-2-(2-nitr
Specifications & Purity≥97%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads

Product Properties

ALogP0.9

Associated Targets(Human)

CYP1A2 Tchem Cytochrome P450 1A2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CNR1 Tclin Cannabinoid receptor 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CYP2C19 Tchem Cytochrome P450 2C19 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DRD2 Tclin D(2) dopamine receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CYP3A4 Tclin Cytochrome P450 3A4 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ESR1 Tclin Estrogen receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GABRA1 Tclin Gamma-aminobutyric acid receptor subunit alpha-1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
NR3C1 Tclin Glucocorticoid receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
AVPR1A Tclin Vasopressin V1a receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HDAC6 Tclin Histone deacetylase 6 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HRH1 Tclin Histamine H1 receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SLC6A3 Tclin Sodium-dependent dopamine transporter (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SLC6A4 Tclin Sodium-dependent serotonin transporter (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PDE4D Tclin cAMP-specific 3',5'-cyclic phosphodiesterase 4D (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PDE3A Tclin cGMP-inhibited 3',5'-cyclic phosphodiesterase A (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PTGS1 Tclin Prostaglandin G/H synthase 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PTGS2 Tclin Prostaglandin G/H synthase 2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CACNA1C Tclin Voltage-dependent L-type calcium channel subunit alpha-1C (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
AURKB Tchem Aurora kinase B (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DRD3 Tclin D(3) dopamine receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CHRM3 Tclin Muscarinic acetylcholine receptor M3 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADRA2B Tclin Alpha-2B adrenergic receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADRA2C Tclin Alpha-2C adrenergic receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR2A Tclin 5-hydroxytryptamine receptor 2A (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADORA2A Tclin Adenosine receptor A2a (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ACHE Tclin Acetylcholinesterase (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADRA2A Tclin Alpha-2A adrenergic receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADRB1 Tclin Beta-1 adrenergic receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADRA1A Tclin Alpha-1A adrenergic receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
AR Tclin Androgen receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MAOA Tclin Amine oxidase [flavin-containing] A (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR2C Tclin 5-hydroxytryptamine receptor 2C (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADORA1 Tclin Adenosine receptor A1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR1A Tclin 5-hydroxytryptamine receptor 1A (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADORA3 Tchem Adenosine receptor A3 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR3A Tclin 5-hydroxytryptamine receptor 3A (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR2B Tclin 5-hydroxytryptamine receptor 2B (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
F2 Tclin Prothrombin (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
EDNRA Tclin Endothelin-1 receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
KCNH2 Tclin Potassium voltage-gated channel subfamily H member 2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
OPRD1 Tclin Delta-type opioid receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
OPRK1 Tclin Kappa-type opioid receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
OPRM1 Tclin Mu-type opioid receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MLNR Tchem Motilin receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
F2 Tclin Thrombin (11687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FDPS Tclin Farnesyl diphosphate synthase (1240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH2 Tclin Histamine H2 receptor (5428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIN1 Tclin Glutamate (NMDA) receptor subunit zeta 1 (122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CACNA1C Tclin Voltage-gated L-type calcium channel alpha-1C subunit (766 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC29A1 Tclin Equilibrative nucleoside transporter 1 (1711 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2B Tclin Alpha-2b adrenergic receptor (4412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2C Tclin Alpha-2c adrenergic receptor (4876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM3 Tclin Muscarinic acetylcholine receptor M3 (7750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TBXA2R Tclin Thromboxane A2 receptor (5717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EDNRA Tclin Endothelin receptor ET-A (5008 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE4A Tclin Phosphodiesterase 4A (1943 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

TPR Trypanothione reductase (189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ampC Beta-lactamase AmpC (62480 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Npy1r Neuropeptide Y receptor type 1 (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cruzipain (33337 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cckar Cholecystokinin A receptor (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pde4d Phosphodiesterase 4D (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella pneumoniae (43867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella typhimurium (15756 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter baumannii (41033 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania infantum (5912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei (78846 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei brucei (13300 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Entamoeba histolytica (2676 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cryptococcus neoformans (21258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Candida albicans (78123 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania amazonensis (3813 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania braziliensis (1091 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania donovani (89745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania major (2877 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania mexicana (936 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma cruzi (99888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trichomonas vaginalis (2376 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Giardia intestinalis (1290 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Toxoplasma gondii (4585 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium berghei (192651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei rhodesiense (7991 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
COS-7 (515 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
H9c2 (3506 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
J774.A1 (2436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LLC-MK2 (227 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vero (26788 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
J774.2 (197 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NIH3T3 (5395 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L6 (7924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L929 (3802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
J774 (3120 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
V79 (1637 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Splenocyte (1641 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
C2C12 (756 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Txnrd1 Thioredoxin reductase 1, cytoplasmic (45279 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Babesia divergens (18 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Names and Identifiers

IUPAC Name N-benzyl-2-(2-nitroimidazol-1-yl)acetamide
INCHI InChI=1S/C12H12N4O3/c17-11(14-8-10-4-2-1-3-5-10)9-15-7-6-13-12(15)16(18)19/h1-7H,8-9H2,(H,14,17)
InChi Key CULUWZNBISUWAS-UHFFFAOYSA-N
Canonical SMILES C1=CC=C(C=C1)CNC(=O)CN2C=CN=C2[N+](=O)[O-]
Isomeric SMILES C1=CC=C(C=C1)CNC(=O)CN2C=CN=C2[N+](=O)[O-]
WGK Germany 3
RTECS NI3340000
PubChem CID 31593
Molecular Weight 260.25

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot NumberCertificate TypeDateItem
K2215246Certificate of AnalysisAug 21, 2024 B133189
K2215245Certificate of AnalysisAug 21, 2024 B133189
K2215244Certificate of AnalysisAug 21, 2024 B133189

Safety and Hazards(GHS)

Pictogram(s) GHS07
Signal Warning
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P271:Use only outdoors or in a well-ventilated area.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P362+P364:Take off contaminated clothing and wash it before reuse.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

P319:Get medical help if you feel unwell.

WGK Germany 3
RTECS NI3340000

Related Documents

References

1. Lívia C L Sá-Barreto,Pricila C Gustmann,Felipe S Garcia,Flávia P Maximiano,Kátia M Novack,Marcílio S S Cunha-Filho.  (2011-12-28)  Modulated dissolution rate from the inclusion complex of antichagasic benznidazole and cyclodextrin using hydrophilic polymer..  Pharmaceutical development and technology,  18  ((5)): (1035-1041).  [PMID:22200091]
2. Miriam Navarro,Francesca F Norman,José Antonio Pérez-Molina,Rogelio López-Vélez.  (2012-07-25)  Benznidazole shortage makes chagas disease a neglected tropical disease in developed countries: data from Spain..  The American journal of tropical medicine and hygiene,  87  ((3)): (489-490).  [PMID:22826485]
3. Rebecca Voelker.  (2012-08-02)  Congenital Chagas disease reported in United States..  JAMA,  308  ((5)): (443-443).  [PMID:22851094]
4. Belinda S Hall,Emma Louise Meredith,Shane R Wilkinson.  (2012-09-06)  Targeting the substrate preference of a type I nitroreductase to develop antitrypanosomal quinone-based prodrugs..  Antimicrobial agents and chemotherapy,  56  ((11)): (5821-5830).  [PMID:22948871]
5. Otacilio C Moreira,Juan David Ramírez,Elsa Velázquez,Myllena F A Dias Melo,Carolina Lima-Ferreira,Felipe Guhl,Sergio Sosa-Estani,Jose Antonio Marin-Neto,Carlos A Morillo,Constança Britto.  (2012-09-18)  Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial..  Acta tropica,  125  ((1)): (23-31).  [PMID:22982466]
6. Sabrina Cencig,Nicolas Coltel,Carine Truyens,Yves Carlier.  (2012-10-16)  Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains..  International journal of antimicrobial agents,  40  ((6)): (527-532).  [PMID:23063742]
7. Juliana Cogo,Angelo de Oliveira Caleare,Tânia Ueda-Nakamura,Benedito Prado Dias Filho,Izabel Cristina Piloto Ferreira,Celso Vataru Nakamura.  (2012-10-17)  Trypanocidal activity of guaianolide obtained from Tanacetum parthenium (L.) Schultz-Bip. and its combinational effect with benznidazole..  Phytomedicine : international journal of phytotherapy and phytopharmacology,  20  ((1)): (59-66).  [PMID:23069248]
8. Ivo Santana Caldas,Paulo Marcos da Matta Guedes,Fabiane Matos dos Santos,Lívia de Figueiredo Diniz,Tassiane Assíria Fontes Martins,Alvaro Fernando da Silva do Nascimento,Maira Araújo Azevedo,Wanderson Geraldo de Lima,Raimundo Marques Nascimento Neto,Rosália Morais Torres,André Talvani,Maria Terezinha Bahia.  (2012-10-31)  Myocardial scars correlate with eletrocardiographic changes in chronic Trypanosoma cruzi infection for dogs treated with Benznidazole..  Tropical medicine & international health : TM & IH,  18  ((1)): (75-84).  [PMID:23107306]
9. María-Jesús Pinazo,Laura Guerrero,Elizabeth Posada,Elena Rodríguez,Dolors Soy,Joaquim Gascon.  (2012-11-02)  Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic chagas disease..  Antimicrobial agents and chemotherapy,  57  ((1)): (390-395).  [PMID:23114763]
10. Ana P M Teston,Wuelton M Monteiro,Daniele Reis,Gleison D P Bossolani,Mônica L Gomes,Silvana M de Araújo,Maria T Bahia,Maria G V Barbosa,Max J O Toledo.  (2012-11-08)  In vivo susceptibility to benznidazole of Trypanosoma cruzi strains from the western Brazilian Amazon..  Tropical medicine & international health : TM & IH,  18  ((1)): (85-95).  [PMID:23130989]
11. José M Ramos,Diego Torrús,Concepción Amador,Francisco Jover,Fabiola Pérez-Chacón,Yamileth Ponce,Francisco J Arjona,Elena Caro,Concepción Martínez-Peinado,Ingrid Gallegos,José M Cuadrado,Antonio Tello,Felix Gutiérrez.  (2012-11-28)  Multicenter epidemiological and clinical study on imported Chagas diseases in Alicante, Spain..  Pathogens and global health,  106  ((6)): (340-345).  [PMID:23182138]
12. Juan P Rigalli,Virginia G Perdomo,Marcelo G Luquita,Silvina S M Villanueva,Agostina Arias,Dirk Theile,Johanna Weiss,Aldo D Mottino,María L Ruiz,Viviana A Catania.  (2012-12-29)  Regulation of biotransformation systems and ABC transporters by benznidazole in HepG2 cells: involvement of pregnane X-receptor..  PLoS neglected tropical diseases,  ((12)): (e1951-e1951).  [PMID:23272261]
13. Jean-Philippe Chippaux,Alejandra Nadin Salas-Clavijo,Jorge Rene Postigo,Dominique Schneider,Jose Antonio Santalla,Laurent Brutus.  (2013-01-09)  Evaluation of compliance to congenital Chagas disease treatment: results of a randomised trial in Bolivia..  Transactions of the Royal Society of Tropical Medicine and Hygiene,  107  ((1)): (1-7).  [PMID:23296694]
14. Darío Leonardi,Claudio J Salomon.  (2013-01-11)  Unexpected performance of physical mixtures over solid dispersions on the dissolution behavior of benznidazole from tablets..  Journal of pharmaceutical sciences,  102  ((3)): (1016-1023).  [PMID:23303640]
15. María-Jesús Pinazo,Gerard Espinosa,Cristina Cortes-Lletget,Elizabeth de Jesús Posada,Edelweiss Aldasoro,Inés Oliveira,Jose Muñoz,Montserrat Gállego,Joaquim Gascon.  (2013-01-26)  Immunosuppression and Chagas disease: a management challenge..  PLoS neglected tropical diseases,  ((1)): (e1965-e1965).  [PMID:23349998]
16. Ignacio Martínez,Benjamín Nogueda,Fernando Martínez-Hernández,Bertha Espinoza.  (2013-02-21)  Microsatellite and mini-exon analysis of Mexican human DTU I Trypanosoma cruzi strains and their susceptibility to nifurtimox and benznidazole..  Vector borne and zoonotic diseases (Larchmont, N.Y.),  13  ((3)): (181-187).  [PMID:23421890]
17. Andrew A Voak,Vithurshaa Gobalakrishnapillai,Karin Seifert,Edina Balczo,Longqin Hu,Belinda S Hall,Shane R Wilkinson.  (2013-08-16)  An essential type I nitroreductase from Leishmania major can be used to activate leishmanicidal prodrugs..  The Journal of biological chemistry,  288  ((40)): (28466-28476).  [PMID:23946481]
18. Sara Braga Honorato,Jorge Souza Mendonça,Nubia Boechat,Alcemira Conceição Oliveira,Josué Mendes Filho,Javier Ellena,Alejandro Pedro Ayala.  (2013-10-01)  Novel polymorphs of the anti-Trypanosoma cruzi drug benznidazole..  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,  118  (389-394).  [PMID:24076454]
19. Andrea Trochine,Guzmán Alvarez,Sandra Corre,Paula Faral-Tello,Rosario Durán,Carlos I Batthyany,Hugo Cerecetto,Mercedes González,Carlos Robello.  (2014-03-19)  Trypanosoma cruzi chemical proteomics using immobilized benznidazole..  Experimental parasitology,  140  (33-38).  [PMID:24632192]
20. Facundo García-Bournissen,Samanta Moroni,Maria Elena Marson,Guillermo Moscatelli,Guido Mastrantonio,Margarita Bisio,Laura Cornou,Griselda Ballering,Jaime Altcheh.  (2014-09-12)  Limited infant exposure to benznidazole through breast milk during maternal treatment for Chagas disease..  Archives of disease in childhood,  100  ((1)): (90-94).  [PMID:25210104]
21. Jennifer Manne-Goehler,Janine M Ramsey,Marco Ocampo Salgado,Veronika J Wirtz,Michael R Reich.  (2014-10-01)  Short report: Increasing access to treatment for Chagas disease: the case of Morelos, Mexico..  The American journal of tropical medicine and hygiene,  91  ((6)): (1125-1127).  [PMID:25266353]
22. Quhuan Li,Qun Lin,Zhong Yun.  (2016-10-28)  Hypoxia-activated cytotoxicity of benznidazole against clonogenic tumor cells..  Cancer biology & therapy,  17  ((12)): (1266-1273).  [PMID:27786593]
23. Glaucia Vilar-Pereira,Andrea Alice da Silva,Isabela Resende Pereira,Rafael Rodrigues Silva,Otacílio Cruz Moreira,Luciana Rodrigues de Almeida,Amanda Santos de Souza,Monica Santos Rocha,Joseli Lannes-Vieira.  (2012-07-31)  Trypanosoma cruzi-induced depressive-like behavior is independent of meningoencephalitis but responsive to parasiticide and TNF-targeted therapeutic interventions..  Brain, behavior, and immunity,  26  ((7)): (1136-1149).  [PMID:22841695]
24. Alejandra B Ciccarelli,Fernanda M Frank,Vanesa Puente,Emilio L Malchiodi,Alcira Batlle,Maria Elisa Lombardo.  (2012-08-08)  Antiparasitic Effect of Vitamin B12 on Trypanosoma cruzi..  Antimicrobial agents and chemotherapy,  56  ((10)): (5315-5320).  [PMID:22869565]
25. Paula F dos Santos,Jerônimo C Ruiz,Rodrigo P P Soares,Douglas S Moreira,Antônio M Rezende,Edson L Folador,Guilherme Oliveira,Alvaro J Romanha,Silvane M F Murta.  (2012-08-09)  Molecular characterization of the hexose transporter gene in benznidazole resistant and susceptible populations of Trypanosoma cruzi..  Parasites & vectors,  (161-161).  [PMID:22871258]
26. Guillermo Cruz-Zetina,Rodolfo del Rio-Rodriguez,Angel Ramos-Ligonio,Ruth López,Victor Monteon.  (2012-08-15)  Decreased intensity of inflammation in benznidazole-treated mice inoculated with Trypanosoma cruzi I stocks from Mexico and persistence of circulating parasites..  The American journal of tropical medicine and hygiene,  87  ((4)): (671-674).  [PMID:22890036]
27. Romina Manarin,María C Lamas,Emanuel Bottasso,Esteban Serra,Silvia Revelli,Claudio J Salomón.  (2012-09-15)  Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi..  Parasitology international,  62  ((1)): (79-81).  [PMID:22975280]
28. D E Perez-Mazliah,M G Alvarez,G Cooley,B E Lococo,G Bertocchi,M Petti,M C Albareda,A H Armenti,R L Tarleton,S A Laucella,R Viotti.  (2012-10-30)  Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study..  The Journal of antimicrobial chemotherapy,  68  ((2)): (424-437).  [PMID:23104493]
29. Ana María Mejía-Jaramillo,Geysson Javier Fernández,Marleny Montilla,Rubén Santiago Nicholls,Omar Triana-Chávez.  (2012-12-18)  [Trypanosoma cruzi strains resistant to benznidazole occurring in Colombia]..  Biomedica : revista del Instituto Nacional de Salud,  32  ((2)): (196-205).  [PMID:23242293]
30. Viviane Rodrigues Esperandim,Daniele da Silva Ferreira,Karen Cristina Souza Rezende,Wilson Roberto Cunha,Juliana Saraiva,Jairo Kenupp Bastos,Márcio Luis Andrade e Silva,Sérgio de Albuquerque.  (2013-01-01)  Evaluation of the in vivo therapeutic properties of (-)-cubebin and (-)-hinokinin against Trypanosoma cruzi..  Experimental parasitology,  133  ((4)): (442-446).  [PMID:23274812]
31. Michelle C Fox,Monica Sircar,Anand Vaidya,Joel T Katz,Neal Lakdawala.  (2013-08-16)  Interactive medical case. A patient with syncope..  The New England journal of medicine,  369  ((7)): (e9-e9).  [PMID:23944325]
32. Jeffrey A Tornheim,Daniel F Lozano Beltran,Robert H Gilman,Mario Castellon,Marco A Solano Mercado,Walter Sullca,Faustino Torrico,Caryn Bern.  (2013-09-27)  Improved completion rates and characterization of drug reactions with an intensive Chagas disease treatment program in rural Bolivia..  PLoS neglected tropical diseases,  ((9)): (e2407-e2407).  [PMID:24069472]
33. Kosuke Yasukawa,Shital M Patel,Charlene A Flash,Charles E Stager,Jerry C Goodman,Laila Woc-Colburn.  (2014-06-04)  Trypanosoma cruzi meningoencephalitis in a patient with acquired immunodeficiency syndrome..  The American journal of tropical medicine and hygiene,  91  ((1)): (84-85).  [PMID:24891470]
34. Juciane Vaz Rêgo,Ana Paula Duarte,Daniel Barbosa Liarte,Francirlene de Carvalho Sousa,Humberto Medeiros Barreto,Jacqueline Bua,Alvaro José Romanha,Gandhi Rádis-Baptista,Silvane Maria Fonseca Murta.  (2014-12-03)  Molecular characterization of Cyclophilin (TcCyP19) in Trypanosoma cruzi populations susceptible and resistant to benznidazole..  Experimental parasitology,  148  (73-80).  [PMID:25450774]
35. Susana Revollo,Bruno Oury,Andrea Vela,Michel Tibayrenc,Denis Sereno.  (2019-10-23)  In Vitro Benznidazole and Nifurtimox Susceptibility Profile of Trypanosoma cruzi Strains Belonging to Discrete Typing Units TcI, TcII, and TcV..  Pathogens (Basel, Switzerland),  ((4)):   [PMID:31635071]

Solution Calculators